SPP1 and lung cancer: Conversely, in chronic disease states increased SPP1 expression is thought to have the opposite effect, as it decreases survival time for patients with lung cancer and is associated with increased Irritable Bowel Disease symptoms (Miao et al., 2021; Nguyen et al., 2022).